Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tacrolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 118 for your search:
Start Over
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 65 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20-03-001, NCT00106392
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-Based Immunosuppressive Protocol
Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684
Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation (Summary Last Modified 05/94)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor:
Protocol IDs: WSU-Z-1093-93, NCI-V94-0363
Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor: Other
Protocol IDs: FHCRC-949.00, NCI-V95-0776
Phase III Randomized Study of Filgrastim for Enhancement After Allogeneic Peripheral Blood Apheresis Cell Transplantation (PBACT) (Summary Last Modified 12/98)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 55
Sponsor: NCI
Protocol IDs: MDA-DM-94106, NCI-G96-1008
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: ASCT0031, COG-ASCT0031, CCG-S9701, NCI-P02-0213, NCT00031824
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000258113, U10CA021115, E1900, ECOG-1900, NCT00049517
TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2003.333, NCT00133887
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1992.00, NCI-2010-00737, P01CA078902, K23HL084054, P01CA018029, P01HL036444, FHCRC-1992.00, 6170, NHLBI-K23-HL084054-01A1, NCT00322101
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: ASCT0431, NCI-2009-01068, CDR0000500131, COG-PBMTC-ONCO51, COG-ASCT0431, U10CA098543, NCT00382109
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 22
Sponsor: NCI, Other
Protocol IDs: ASCT0631, NCI-2009-01069, COG-ASCT0631, COG-PBMTC-STC051, CDR0000532926, U10CA098543, NCT00450450
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROGAST, NCT00180089
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: BMTCTN0402, U01HL069294, U01HL069294-05, NCT00406393
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 15 to 55
Sponsor: NCI, Other
Protocol IDs: DM94-064, P30CA016672, MDA-DM-94064, NCI-G96-0999, CDR0000065033, NCT00002831
Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 12472, ACHE, BCM-H-12472, H 12472, BCM-ACHE, NCT00056966
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-065, X05175, NCT00369226
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 55
Sponsor: NCI, Other
Protocol IDs: 06-125, MSKCC-06125, NCT00423514
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2006-0803, NCT00410982
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: BMTCTN0301, U01HL069294, 5U01HL069294-05, FHCRC-2051.00, NCT00326417
Fludarabine and PK-Directed Busulfan With or Without ATG Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI, Other
Protocol IDs: LCCC 0510, P30CA016086, CDR0000550145, UNC-LCCC-0510, NCT00448357
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID00-132, NCT00506922
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 30 and under
Sponsor: Other
Protocol IDs: L 9471, NCT00529360
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2008.095, NCT00810602
Start Over